ContractClinical Study Agreement • August 26th, 2024
Contract Type FiledAugust 26th, 2024TWO-PARTY CLINICAL STUDY AGREEMENT DVOUSTRANNÁ SMLOUVA O KLINICKÉ STUDII PARTIES STRANY This clinical study agreement (“Agreement”) is effective as of the date of the last of signature (the “Effective Date”) by and between Pierre Fabre Medicament, a company incorporated in France under company registration number 326118502 with its principal office and place of business at 45, Place Abel Gance, F-92100 Boulogne, France (“Sponsor”), and Fakultní nemocnice Královské Vinohrady, ID: 00064173, VAT ID: CZ00064173 a clinical research site with its principal office and place of business at Šrobárova 1150/50, 100 34 Prague 10, Czech Republic (“Institution”), individually referred to as a “Party” and collectively as “Parties”. Tato smlouva o klinické studii (dále jen„Smlouva“) nabývá účinnosti k datu posledního podpisu (dále jen „datum účinnosti“) mezi společností Pierre Fabre Medicament zaregistrovanou ve Francii pod registračním číslem 326118502 se sídlem a místem obchodní činnosti na adre